FDA's No. 2 on RWE, Hype and Speeding Drug Development

Retrieved on: 2019-07-26 03:41:15

Tags for this article:

Hype cycle

Food and Drug Administration

Click the tags to see associated articles and topics

FDA's No. 2 on RWE, Hype and Speeding Drug Development. View article details on hiswai:

Excerpt

<div>Abernathy came to FDA less than a year ago from Roche's <b>Flatiron Health</b>, which is at the forefront of the real-world data space, and she said she ...</div>

Article found on:

View Original Article